New collaboration to aid the development of drugs to treat cancers
By leafcutter_admin | Cancer and Cell Biology, Disease Area, Lab, News & Events, Research, Research Area, Tumours, Vascular Biology and Stromal TargetingCancer immunotherapies, including checkpoint blocking antibodies such as MSD’s Keytruda, have shown remarkable results in a number of different cancer types. However the effectiveness of these treatments may be enhanced…
New drug to supercharge immune cells in the fight against cancer
By leafcutter_admin | Cancer and Cell Biology, Disease Area, News & Events, Research, Research Area, TumoursMany tumours can become resistant to the body’s immune system by creating a barrier of tangled blood vessels that feed the tumour while locking out immune cells that would attack…
Ground-breaking new study doubles the estimate of our functional genes
By leafcutter_admin | Cancer, Cancer and Cell Biology, Disease Area, Genes, Lab, News & Events, Research, Research Area, Systems Biology and GenomicsThe findings, published in Nature, were the latest work of the FANTOM5 consortium, a group of researchers from Japan and Australia led by Professor Alistair Forrest from the Perkins and The University of…
New method to fight hard to treat breast cancers
By leafcutter_admin | Breast Cancer, Cancer and Cell Biology, Cancer Epigenetics, Disease Area, Lab, News & Events, Research, Research AreaThe research led by Perkins researcher Dr Anabel Sorolla involves the use of nanoparticles to deliver a series of anti-cancer agents directly to the tumour. The study focused on triple…
Perkins researchers turn on cancer killing genes
By leafcutter_admin | Cancer and Cell Biology, Cancer Epigenetics, Disease Area, Lab, News & Events, Research, Research Area, TumoursDr Benjamin Garcia Bloj, along with his labmates from the Perkins Cancer Epigenetics Laboratory headed by Associate Professor Pilar Blancafort, used a gene-editing technology called CRISPR to ‘wake up’ key tumour suppressors to…